CLINICAL_TRIALS
trial_result
· 2015-10-30
Clinical Trial Update: Safety and Efficacy Study of Dysport RU and Glabellar Lines [Phase 2]
Summary
Phase 2 trial updating safety and efficacy for Dysport RU in treating glabellar frown lines; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ipsen | Conditions: Glabellar Frown Lines | Phase 2 | Status: COMPLETED | Results posted: 2015-10-30